Xenetic Biosciences, Inc. (XBIO)

Xenetic Biosciences Revenue

In the year 2023, Xenetic Biosciences had annual revenue of $2.54M with 48.80% growth. Revenue in the quarter ending December 31, 2023 was $671.96K with 37.99% year-over-year growth.

• Revenue (ttm): $2.54M
• Revenue Growth: +48.80%
• P/S Ratio: 2.37
• Revenue / Employee: $634,997
• Employees: 4
• Market Cap: 6.01M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	2.54M	833.06K	48.80%
Dec 31, 2022	1.71M	546.23K	47.06%
Dec 31, 2021	1.16M	723.75K	165.64%
Dec 31, 2020	436.94K	419.88K	2,460.31%
Dec 31, 2019	17.07K	-	-
Dec 31, 2018	0	-	-
Dec 31, 2017	7.59M	4.59M	152.83%
Dec 31, 2016	3.00M	-	-
Dec 31, 2015	0	-	-
Dec 31, 2014	0	-	-
Dec 31, 2013	1.00M	706.40K	240.60%
Dec 31, 2012	293.60K	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.